List of Tables
Table 1. Global Parkinson Disease Drug Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Parkinson Disease Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Parkinson Disease Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Parkinson Disease Drug Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Parkinson Disease Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Parkinson Disease Drug Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Parkinson Disease Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Parkinson Disease Drug Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Parkinson Disease Drug Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Parkinson Disease Drug Revenue by Company (2020-2025) & (US$ Million)
Table 11. Parkinson Disease Drug Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Parkinson Disease Drug Players by Revenue (US$ Million) in 2024
Table 13. Global Parkinson Disease Drug Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Parkinson Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Disease Drug as of 2024)
Table 15. Global Parkinson Disease Drug Companies Headquarters
Table 16. Date of International Companies Enter into Parkinson Disease Drug Market
Table 17. Global Parkinson Disease Drug Companies Product & Service
Table 18. Global Parkinson Disease Drug Mergers & Acquisitions, Expansion Plans
Table 19. Merck Corporation Information
Table 20. Merck Description and Business Overview
Table 21. Merck Parkinson Disease Drug Product
Table 22. Merck Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Merck Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 24. Merck Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 25. Merck Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 26. Merck Recent Developments
Table 27. Akorn Corporation Information
Table 28. Akorn Description and Business Overview
Table 29. Akorn Parkinson Disease Drug Product
Table 30. Akorn Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Akorn Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 32. Akorn Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 33. Akorn Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 34. Akorn Recent Developments
Table 35. GSK Corporation Information
Table 36. GSK Description and Business Overview
Table 37. GSK Parkinson Disease Drug Product
Table 38. GSK Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. GSK Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 40. GSK Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 41. GSK Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 42. GSK Recent Developments
Table 43. Novartis Corporation Information
Table 44. Novartis Description and Business Overview
Table 45. Novartis Parkinson Disease Drug Product
Table 46. Novartis Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Novartis Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 48. Novartis Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 49. Novartis Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 50. Novartis Recent Developments
Table 51. Boehringer Ingelheim Corporation Information
Table 52. Boehringer Ingelheim Description and Business Overview
Table 53. Boehringer Ingelheim Parkinson Disease Drug Product
Table 54. Boehringer Ingelheim Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Boehringer Ingelheim Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 56. Boehringer Ingelheim Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 57. Boehringer Ingelheim Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 58. Boehringer Ingelheim Recent Developments
Table 59. Teva Pharmaceutical Corporation Information
Table 60. Teva Pharmaceutical Description and Business Overview
Table 61. Teva Pharmaceutical Parkinson Disease Drug Product
Table 62. Teva Pharmaceutical Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Teva Pharmaceutical Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 64. Teva Pharmaceutical Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 65. Teva Pharmaceutical Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 66. Teva Pharmaceutical Recent Developments
Table 67. Abbvie Corporation Information
Table 68. Abbvie Description and Business Overview
Table 69. Abbvie Parkinson Disease Drug Product
Table 70. Abbvie Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Abbvie Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 72. Abbvie Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 73. Abbvie Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 74. Abbvie Recent Developments
Table 75. Kyowa Hakko Kirin Pharma Corporation Information
Table 76. Kyowa Hakko Kirin Pharma Description and Business Overview
Table 77. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product
Table 78. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Kyowa Hakko Kirin Pharma Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 80. Kyowa Hakko Kirin Pharma Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 81. Kyowa Hakko Kirin Pharma Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 82. Kyowa Hakko Kirin Pharma Recent Developments
Table 83. Astellas Pharma Corporation Information
Table 84. Astellas Pharma Description and Business Overview
Table 85. Astellas Pharma Parkinson Disease Drug Product
Table 86. Astellas Pharma Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Astellas Pharma Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 88. Astellas Pharma Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 89. Astellas Pharma Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 90. Astellas Pharma Recent Developments
Table 91. Desitin Arzneimittel Corporation Information
Table 92. Desitin Arzneimittel Description and Business Overview
Table 93. Desitin Arzneimittel Parkinson Disease Drug Product
Table 94. Desitin Arzneimittel Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Desitin Arzneimittel Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 96. Desitin Arzneimittel Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 97. Desitin Arzneimittel Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 98. Desitin Arzneimittel Recent Developments
Table 99. Endo Pharmaceuticals Corporation Information
Table 100. Endo Pharmaceuticals Description and Business Overview
Table 101. Endo Pharmaceuticals Parkinson Disease Drug Product
Table 102. Endo Pharmaceuticals Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Endo Pharmaceuticals Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 104. Endo Pharmaceuticals Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 105. Endo Pharmaceuticals Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 106. Endo Pharmaceuticals Recent Developments
Table 107. F.Hoffmann-La Roche Corporation Information
Table 108. F.Hoffmann-La Roche Description and Business Overview
Table 109. F.Hoffmann-La Roche Parkinson Disease Drug Product
Table 110. F.Hoffmann-La Roche Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. F.Hoffmann-La Roche Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 112. F.Hoffmann-La Roche Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 113. F.Hoffmann-La Roche Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 114. F.Hoffmann-La Roche Recent Developments
Table 115. H.Lundbeck Corporation Information
Table 116. H.Lundbeck Description and Business Overview
Table 117. H.Lundbeck Parkinson Disease Drug Product
Table 118. H.Lundbeck Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. H.Lundbeck Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 120. H.Lundbeck Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 121. H.Lundbeck Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 122. H.Lundbeck Recent Developments
Table 123. Valeant Corporation Information
Table 124. Valeant Description and Business Overview
Table 125. Valeant Parkinson Disease Drug Product
Table 126. Valeant Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Valeant Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 128. Valeant Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 129. Valeant Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 130. Valeant Recent Developments
Table 131. Apokyn Corporation Information
Table 132. Apokyn Description and Business Overview
Table 133. Apokyn Parkinson Disease Drug Product
Table 134. Apokyn Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Apokyn Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 136. Apokyn Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 137. Apokyn Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 138. Apokyn Recent Developments
Table 139. Orion Corporation Information
Table 140. Orion Description and Business Overview
Table 141. Orion Parkinson Disease Drug Product
Table 142. Orion Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Orion Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 144. Orion Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 145. Orion Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 146. Orion Recent Developments
Table 147. Stada Arzneimittel Corporation Information
Table 148. Stada Arzneimittel Description and Business Overview
Table 149. Stada Arzneimittel Parkinson Disease Drug Product
Table 150. Stada Arzneimittel Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Stada Arzneimittel Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 152. Stada Arzneimittel Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 153. Stada Arzneimittel Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 154. Stada Arzneimittel Recent Developments
Table 155. US WorldMeds Corporation Information
Table 156. US WorldMeds Description and Business Overview
Table 157. US WorldMeds Parkinson Disease Drug Product
Table 158. US WorldMeds Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. US WorldMeds Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 160. US WorldMeds Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 161. US WorldMeds Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 162. US WorldMeds Recent Developments
Table 163. Bausch Health Corporation Information
Table 164. Bausch Health Description and Business Overview
Table 165. Bausch Health Parkinson Disease Drug Product
Table 166. Bausch Health Parkinson Disease Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. Bausch Health Revenue Proportion of Parkinson Disease Drug by Product in 2024
Table 168. Bausch Health Revenue Proportion of Parkinson Disease Drug by Application in 2024
Table 169. Bausch Health Revenue Proportion of Parkinson Disease Drug by Geographic Area in 2024
Table 170. Bausch Health Recent Developments
Table 171. North America Parkinson Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 172. North America Parkinson Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 173. North America Parkinson Disease Drug Revenue by Type (2020-2025) & (US$ Million)
Table 174. North America Parkinson Disease Drug Revenue by Application (2020-2025) & (US$ Million)
Table 175. Asia-Pacific Parkinson Disease Drug Revenue by Region (2020-2025) & (US$ Million)
Table 176. Asia-Pacific Parkinson Disease Drug Revenue by Region (2026-2031) & (US$ Million)
Table 177. Asia-Pacific Parkinson Disease Drug Revenue by Type (2020-2025) & (US$ Million)
Table 178. Asia-Pacific Parkinson Disease Drug Revenue by Application (2020-2025) & (US$ Million)
Table 179. Europe Parkinson Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 180. Europe Parkinson Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 181. Europe Parkinson Disease Drug Revenue by Type (2020-2025) & (US$ Million)
Table 182. Europe Parkinson Disease Drug Revenue by Application (2020-2025) & (US$ Million)
Table 183. Latin America Parkinson Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 184. Latin America Parkinson Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 185. Latin America Parkinson Disease Drug Revenue by Type (2020-2025) & (US$ Million)
Table 186. Latin America Parkinson Disease Drug Revenue by Application (2020-2025) & (US$ Million)
Table 187. Middle East and Africa Parkinson Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 188. Middle East and Africa Parkinson Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 189. Middle East and Africa Parkinson Disease Drug Revenue by Type (2020-2025) & (US$ Million)
Table 190. Middle East and Africa Parkinson Disease Drug Revenue by Application (2020-2025) & (US$ Million)
Table 191. Parkinson Disease Drug Key Raw Materials, Industry Status and Trend
Table 192. Parkinson Disease Drug Key Raw Materials and Upstream Suppliers
Table 193. Parkinson Disease Drug Clients Status and Trend
Table 194. Parkinson Disease Drug Typical Clients
Table 195. Parkinson Disease Drug Distributors
Table 196. Parkinson Disease Drug Market Trends
Table 197. Parkinson Disease Drug Market Drivers
Table 198. Parkinson Disease Drug Market Challenges
Table 199. Parkinson Disease Drug Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinson Disease Drug Product Picture
Figure 2. Global Parkinson Disease Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Parkinson Disease Drug Revenue Market Share by Type in 2024 & 2031
Figure 4. Sinemet-CR Product Picture
Figure 5. Trastal Product Picture
Figure 6. Madopar Product Picture
Figure 7. COMT Inhibitor Product Picture
Figure 8. Other Product Picture
Figure 9. Global Parkinson Disease Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 10. Global Parkinson Disease Drug Revenue Market Share by Application in 2024 & 2031
Figure 11. Under 40 Years Old
Figure 12. 40-65 Years Old
Figure 13. Above 65 Years Old
Figure 14. Parkinson Disease Drug Report Years Considered
Figure 15. Global Parkinson Disease Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Parkinson Disease Drug Market Size (2020-2031) & (US$ Million)
Figure 17. Global Parkinson Disease Drug Market Size Market Share by Region: 2024 Versus 2031
Figure 18. Global Parkinson Disease Drug Revenue Market Share by Region (2020-2031)
Figure 19. Global Parkinson Disease Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Global Parkinson Disease Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Sinemet-CR of Parkinson Disease Drug Revenue Market Share by Application, 2024 VS 2031
Figure 22. Trastal of Parkinson Disease Drug Revenue Market Share by Application, 2024 VS 2031
Figure 23. Madopar of Parkinson Disease Drug Revenue Market Share by Application, 2024 VS 2031
Figure 24. COMT Inhibitor of Parkinson Disease Drug Revenue Market Share by Application, 2024 VS 2031
Figure 25. Other of Parkinson Disease Drug Revenue Market Share by Application, 2024 VS 2031
Figure 26. Parkinson Disease Drug Revenue Share by Company (2024)
Figure 27. Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Sinemet-CR Revenue Proportion by Company in 2024
Figure 29. Trastal Revenue Proportion by Company in 2024
Figure 30. Madopar Revenue Proportion by Company in 2024
Figure 31. COMT Inhibitor Revenue Proportion by Company in 2024
Figure 32. Other Revenue Proportion by Company in 2024
Figure 33. North America Parkinson Disease Drug Revenue 2020-2031 (US$ Million)
Figure 34. North America Parkinson Disease Drug Revenue Market Share by Type (2020-2025)
Figure 35. North America Parkinson Disease Drug Revenue Market Share by Application (2020-2025)
Figure 36. Asia-Pacific Parkinson Disease Drug Revenue 2020-2031 (US$ Million)
Figure 37. Asia-Pacific Parkinson Disease Drug Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Parkinson Disease Drug Revenue Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Parkinson Disease Drug Revenue Market Share by Application (2020-2025)
Figure 40. Europe Parkinson Disease Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Parkinson Disease Drug Revenue Market Share by Country (2020-2031)
Figure 42. Europe Parkinson Disease Drug Revenue Market Share by Type (2020-2025)
Figure 43. Europe Parkinson Disease Drug Revenue Market Share by Application (2020-2025)
Figure 44. Latin America Parkinson Disease Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Latin America Parkinson Disease Drug Revenue Market Share by Country (2020-2031)
Figure 46. Latin America Parkinson Disease Drug Revenue Market Share by Type (2020-2025)
Figure 47. Latin America Parkinson Disease Drug Revenue Market Share by Application (2020-2025)
Figure 48. Middle East and Africa Parkinson Disease Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Middle East and Africa Parkinson Disease Drug Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Parkinson Disease Drug Revenue Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Parkinson Disease Drug Revenue Market Share by Application (2020-2025)
Figure 52. Parkinson Disease Drug Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Parkinson Disease Drug Raw Materials by Region in 2024
Figure 54. Parkinson Disease Drug Distribution Channels
Figure 55. Global Parkinson Disease Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Parkinson Disease Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
